We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£495.00
The 2013-2018 Outlook for Cystic Fibrosis Drugs in India
Price data last checked 139 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 24 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 592 days • 592 data points (No recent data available)
Price Distribution
Price distribution over 592 days • 1 price levels
Price Analysis
Most common price: £495 (592 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 592 days
Product Specifications
- Format
- paperback
- ASIN
- B00E18QHZY
- Domain
- Amazon UK
- Release Date
- 19 June 2013
- Listed Since
- 23 July 2013
Similar Products You Might Like
The 2011-2016 Outlook for Cystic Fibrosis Drugs in Asia & Oceana
The 2025-2030 World Outlook for Cystic Fibrosis Drugs
The 2025-2030 World Outlook for Cystic Fibrosis Therapeutics
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in India
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in the United States
The 2013-2018 Outlook for Chronic Obstructive Pulmonary Disease (COPD) Therapeutics in India
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in China
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in China
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in India
Cystic Fibrosis: Heterogeneity and Personalized Treatment
IntechOpen
Cystic Fibrosis: Facts, Management and Advances
IntechOpen
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments for US Zip Codes
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments for US Zip Codes
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in Japan
The 2023-2028 Outlook for Idiopathic Pulmonary Fibrosis Treatments in Japan
The 2013-2018 Outlook for Non-Prescription Cough and Cold Capsules and Tablets in India
The 2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis Treatments
The 2025-2030 World Outlook for Idiopathic Pulmonary Fibrosis
The 2013-2018 Outlook for Prescription Non-Narcotic Cough Preparations and Expectorants in India
The 2013-2018 Outlook for Medical Fiber Optics in India
The 2013-2018 Outlook for Bronchial Dilator and Anti-Asthmatic Pharmaceutical Preparations in India
The 2013-2018 Outlook for Non-Prescription Cough Syrups in India
The 2023-2028 World Outlook for Pulmonary Fibrosis Treatments
